253 related articles for article (PubMed ID: 35663970)
1. Natural Compounds Tapinarof and
Tsuji G; Hashimoto-Hachiya A; Matsuda-Taniguchi T; Takai-Yumine A; Takemura M; Yan X; Furue M; Nakahara T
Front Immunol; 2022; 13():745997. PubMed ID: 35663970
[TBL] [Abstract][Full Text] [Related]
2. IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis.
Vu YH; Hashimoto-Hachiya A; Takemura M; Yumine A; Mitamura Y; Nakahara T; Furue M; Tsuji G
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321923
[TBL] [Abstract][Full Text] [Related]
3. Regulatory Mechanism of the IL-33-IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.
Tsuji G; Yamamura K; Kawamura K; Kido-Nakahara M; Ito T; Nakahara T
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834081
[TBL] [Abstract][Full Text] [Related]
4. Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans.
Smith SH; Jayawickreme C; Rickard DJ; Nicodeme E; Bui T; Simmons C; Coquery CM; Neil J; Pryor WM; Mayhew D; Rajpal DK; Creech K; Furst S; Lee J; Wu D; Rastinejad F; Willson TM; Viviani F; Morris DC; Moore JT; Cote-Sierra J
J Invest Dermatol; 2017 Oct; 137(10):2110-2119. PubMed ID: 28595996
[TBL] [Abstract][Full Text] [Related]
5. Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis.
Lee J; Song KM; Jung CH
Phytomedicine; 2021 Jan; 81():153418. PubMed ID: 33302042
[TBL] [Abstract][Full Text] [Related]
6. Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent.
Bissonnette R; Stein Gold L; Rubenstein DS; Tallman AM; Armstrong A
J Am Acad Dermatol; 2021 Apr; 84(4):1059-1067. PubMed ID: 33157177
[TBL] [Abstract][Full Text] [Related]
7. Galactomyces fermentation filtrate prevents T helper 2-mediated reduction of filaggrin in an aryl hydrocarbon receptor-dependent manner.
Takei K; Mitoma C; Hashimoto-Hachiya A; Takahara M; Tsuji G; Nakahara T; Furue M
Clin Exp Dermatol; 2015 Oct; 40(7):786-93. PubMed ID: 25786502
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis.
Tsuji G; Hashimoto-Hachiya A; Kiyomatsu-Oda M; Takemura M; Ohno F; Ito T; Morino-Koga S; Mitoma C; Nakahara T; Uchi H; Furue M
Cell Death Dis; 2017 Jul; 8(7):e2931. PubMed ID: 28703805
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the aryl hydrocarbon receptor in patients with chronic inflammatory skin diseases.
Kim HO; Kim JH; Chung BY; Choi MG; Park CW
Exp Dermatol; 2014 Apr; 23(4):278-81. PubMed ID: 24521260
[TBL] [Abstract][Full Text] [Related]
10. The opposite effect of tapinarof between IMQ and IL-23 induced psoriasis mouse models.
Zhu X; Han R; Tian X; Hochgerner M; Li H; Wang J; Xia J
Exp Dermatol; 2024 Jan; 33(1):e14862. PubMed ID: 37350230
[TBL] [Abstract][Full Text] [Related]
11. Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.
Furue M; Hashimoto-Hachiya A; Tsuji G
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683543
[TBL] [Abstract][Full Text] [Related]
12. Aryl Hydrocarbon Receptor Activation Downregulates IL-33 Expression in Keratinocytes via Ovo-Like 1.
Tsuji G; Hashimoto-Hachiya A; Yen VH; Miake S; Takemura M; Mitamura Y; Ito T; Murata M; Furue M; Nakahara T
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32214018
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic Dermatitis.
Eichenfield LF; Silverberg JI; Hebert AA; Chovatiya R; Brown PM; McHale KA; Rubenstein DS; Tallman AM
J Drugs Dermatol; 2024 Feb; 23(2):23-28. PubMed ID: 38306128
[TBL] [Abstract][Full Text] [Related]
14. The Therapeutic Aryl Hydrocarbon Receptor-Modulating Agent Tapinarof Regulates SEMA3A Expression in Human Keratinocytes through NRF2.
Tsuji G; Yumine A; Yamamura K; Takemura M; Kido-Nakahara M; Ito T; Nakahara T
J Invest Dermatol; 2024 Mar; 144(3):710-713.e8. PubMed ID: 37838333
[No Abstract] [Full Text] [Related]
15. Tapinarof Cream 1%: First Approval.
Keam SJ
Drugs; 2022 Jul; 82(11):1221-1228. PubMed ID: 35939180
[TBL] [Abstract][Full Text] [Related]
16. Role of Aryl Hydrocarbon Receptor Activation and Autophagy in Psoriasis-Related Inflammation.
Kim HR; Kang SY; Kim HO; Park CW; Chung BY
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32235789
[TBL] [Abstract][Full Text] [Related]
17. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
Forrester AR; Elias MS; Woodward EL; Graham M; Williams FM; Reynolds NJ
J Dermatol Sci; 2014 Jan; 73(1):10-22. PubMed ID: 24161567
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor and IL-13 signaling crosstalk in human keratinocytes and atopic dermatitis.
Proper SP; Dwyer AT; Appiagyei A; Felton JM; Ben-Baruch Morgenstern N; Marlman JM; Kotliar M; Barski A; Troutman TD; Rothenberg ME; Mersha TB; Azouz NP
Front Allergy; 2024; 5():1323405. PubMed ID: 38344408
[TBL] [Abstract][Full Text] [Related]
19.
Yan X; Tsuji G; Hashimoto-Hachiya A; Furue M
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362566
[TBL] [Abstract][Full Text] [Related]
20. The Expression and Regulation of Interleukin-33 in Human Epidermal Keratinocytes: A New Mediator of Atopic Dermatitis and Its Possible Signaling Pathway.
Du HY; Fu HY; Li DN; Qiao Y; Wang QW; Liu W
J Interferon Cytokine Res; 2016 Sep; 36(9):552-62. PubMed ID: 27348082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
